This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

DaVita Patient Vaccinations Exceed Goals

DaVita®, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, announced that the company has exceeded its goal of vaccinating 90 percent of its dialysis patients for influenza and pneumonia this flu season.

As of Nov. 18, DaVita had vaccinated 91.6 percent of its patients for influenza and 92.3 percent of its patients for pneumonia.

DaVita recognizes that vaccinations are critical for protection against viruses in kidney patients and therefore offers the vaccines at no cost to patients. To reach the 90 percent goal, DaVita teammates and attending physicians worked together to educate patients on the importance of getting vaccinated.

"I am grateful for the information my caregivers provided about vaccinations," said DaVita patient Joe Garcia at DaVita Beeville Renal Center in Beeville, Texas. "Since I also work as a school bus driver, it’s important for me to stay healthy and now I understand how getting vaccinated plays a vital role in my health."

Studies have shown that high vaccination rates relate directly to fewer hospitalizations, which can lead to a better quality of life for dialysis patients. To combat the spread of the seasonal flu virus DaVita provides flu vaccines for its patients and teammates.

"Seasonal flu can be especially harmful to patients with kidney disease because of their increased risk of serious complications," explained Dr. Allen R. Nissenson, DaVita's chief medical officer. "At DaVita we are committed to improving quality of life for patients, which includes education on the importance of vaccinations."

DaVita also encourages anyone who has physical contact with a dialysis patient to receive a flu vaccination. According to the Centers for Disease Control and Prevention, seasonal flu activity can begin as early as October and continue to occur as late as May. Flu activity most commonly peaks in the U.S. in January or February.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.03 -2.90%
FB $116.73 7.20%
GOOG $691.02 -2.10%
TSLA $247.54 -1.60%
YHOO $36.59 -0.97%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs